期刊
STEM CELL REPORTS
卷 16, 期 2, 页码 252-263出版社
CELL PRESS
DOI: 10.1016/j.stemcr.2020.12.018
关键词
-
资金
- Intramural Research Programs of the National Eye Institute [ZIAEY000450, ZIAEY000546]
- National Institute of Allergy and Infectious Diseases, National Institutes of Health
Mutations in the CRX gene lead to distinct retinopathy phenotypes and early-onset vision impairment. Using iPSCs from patients with CRX mutations, researchers established in vitro models of CRX-LCA and found that AAV-mediated CRX gene augmentation therapy partially restored defective photoreceptor maturation and opsins expression. This study provides proof-of-concept for developing gene therapy for dominant CRX-LCA and other CRX retinopathies.
Mutations in the photoreceptor transcription factor gene cone-rod homeobox (CRX) lead to distinct retinopathy phenotypes, including early-onset vision impairment in dominant Leber congenital amaurosis (LCA). Using induced pluripotent stem cells (iPSCs) from a patient with CRX-I138fs48 mutation, we established an in vitro model of CRX-LCA in retinal organoids that showed defective photoreceptor maturation by histology and gene profiling, with diminished expression of visual opsins. Adeno-associated virus (AAV)-mediated CRX gene augmentation therapy partially restored photoreceptor phenotype and expression of phototransduction-related genes as determined by single-cell RNA-sequencing. Retinal organoids derived from iPSCs of a second dominant CRX-LCA patient carrying K88N mutation revealed the loss of opsin expression as a common phenotype, which was alleviated by AAV-mediated augmentation of CRX. Our studies provide a proof-of-concept for developing gene therapy of dominant CRX-LCA and other CRX retinopathies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据